Phase 3 Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older
- You have been diagnosed with cancer in the skin (melanoma), breast, or head and neck area (including melanoma in the head and neck)
- If you have melanoma, it must be located on the arms, legs, or in the head and neck area
- You are already scheduled to have a sentinel node (a type of lymph node biopsy) surgery at the NKI-AvL hospital
- You are willing and able to give written consent to take part in the trial
Who may not be able to join:
- You are currently pregnant
- You have had a known serious allergic reaction to the study medication, or to eggs or egg-based products
- You have certain heart or lung conditions, such as abnormal connections between blood vessels in the heart or lungs, serious heart artery disease, or serious lung disease, which make the contrast agent used in this trial unsuitable for you (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Quirijn Tummers, The Netherlands Cancer Institute
Phone: +31205121751
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sensitivity of the CEUS SN localization method
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.